Valdemarsson S, Hedner P, Nilsson-Ehle P
Eur J Clin Invest. 1982 Oct;12(5):423-8. doi: 10.1111/j.1365-2362.1982.tb00690.x.
Plasma lipoprotein concentrations, activities of hepatic lipase and lipoprotein lipase in post-heparin plasma, and the removal rate of exogenous triglyceride were measured in fourteen patients with severe primary hypothyroidism before and after 4 months substitution therapy with 1-thyroxine. Before treatment plasma LDL cholesterol concentrations were markedly increased while HDL cholesterol and plasma triglycerides were in the upper reference range. Thyroxine substitution led to a normalization of LDL cholesterol in all patients. Plasma triglycerides and HDL cholesterol decreased moderately. Hepatic lipase and lipoprotein lipase activities were initially reduced but increased significantly after treatment, by about 170% and 55%, respectively. The increase in hepatic lipase activities was significantly correlated to the increase in serum triiodothyronine levels and also to the reduction in LDL cholesterol concentrations. The decrease in LDL cholesterol was also significantly correlated to the increase in serum triiodothyronine concentration. In two patients initially treated with triiodothyronine, the activity of hepatic lipase, but not that of lipoprotein lipase, increased after 24 and 48 h, while LDL cholesterol levels decreased substantially. We suggest that the reduced activities of hepatic lipase as well as of lipoprotein lipase are important pathogenetic factors for the dyslipoproteinaemia occurring in hypothyroidism and that the low serum triiodothyronine concentration is of major importance for the alterations in lipid transport.
对14例重度原发性甲状腺功能减退症患者在接受左旋甲状腺素替代治疗4个月前后,测定了血浆脂蛋白浓度、肝素后血浆中肝脂酶和脂蛋白脂酶的活性以及外源性甘油三酯的清除率。治疗前,血浆低密度脂蛋白胆固醇浓度显著升高,而高密度脂蛋白胆固醇和血浆甘油三酯处于参考范围上限。甲状腺素替代治疗使所有患者的低密度脂蛋白胆固醇恢复正常。血浆甘油三酯和高密度脂蛋白胆固醇适度下降。肝脂酶和脂蛋白脂酶活性最初降低,但治疗后显著升高,分别升高约170%和55%。肝脂酶活性的增加与血清三碘甲状腺原氨酸水平的升高以及低密度脂蛋白胆固醇浓度的降低显著相关。低密度脂蛋白胆固醇的降低也与血清三碘甲状腺原氨酸浓度的升高显著相关。在最初接受三碘甲状腺原氨酸治疗的2例患者中,肝脂酶活性在24小时和48小时后升高,而脂蛋白脂酶活性未升高,同时低密度脂蛋白胆固醇水平大幅下降。我们认为,肝脂酶和脂蛋白脂酶活性降低是甲状腺功能减退症中发生血脂蛋白异常血症的重要发病因素,而血清三碘甲状腺原氨酸浓度低对脂质转运改变至关重要。